跳到正文
  1. ClinicalTrials.gov API v2 · 登记更新

    肿瘤学:Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma

    原文摘录:This phase I/II trial studies the side effects and the best dose of selumetinib and how well it works in treating or re-treating young patients with low grade glioma that has come back (recurrent) or does not respond to treatment (refractory).

    关注理由:这条肿瘤学内容涉及相关临床或研究问题,建议查看原文中的方法与适用范围。

  1. WHO · Official News OData

    内分泌与代谢:One in four adolescents worldwide reported no active days in the previous week

    原文摘录:One in four adolescents worldwide reported not getting at least 60 minutes of physical activity on any day in the previous week. … Stand with science”, the theme of World Health Day 2026, marks a year-long campaign to highlight science as the foundation for protecting health and well-being worldwide

    关注理由:这条内分泌与代谢资料适合作为深入阅读入口,尤其要关注研究方法与结论是否匹配。

  2. WHO · Official News OData

    感染病学:Progress against neglected tropical diseases requires sustained action

    原文摘录:WHO / Monika Mey Local health workers in Cambodia are trained in surveillance techniques, including stool examination using Kato-Katz, to detect schistosomiasis eggs, identify potential hotspots and support early detection and treatment. … int Related Global report on neglected tropical diseases 2026 Ending the neglect to attain the Sustainable Development Goals: A road map for neglected tropical diseases 2021–2030 WHO's work on neglected tropical diseases More WHO Global Neglected Tropical Diseases Programme

    关注理由:关于感染病学的这条内容有明确出处,主要发现和适用人群可在原文中继续核查。

  1. WHO · Disease Outbreak News OData

    神经内科:Shamonda virus in human - France

    原文摘录:See all DONs related to this event Situation at a glance On 20 October 2026, the National IHR Focal Point (NFP) of France notified WHO regarding the first documented human infection with Shamonda virus (SHAV). … item/2026-DON623

    关注理由:这篇神经内科资料可用于了解领域进展,研究设计、结果和局限性值得一起阅读。

  1. FDA · MedWatch Safety Alerts

    肾脏病学:Early Alert: B. Braun Medical Inc. Removes Streamline Bloodline Set for Dialog+

    原文摘录:CDRH is issuing this Early Alert to notify the public of a potentially high-risk device issue. The FDA will keep the public informed and update this web page as significant new information becomes available. Affected Product The FDA is aware that B. … Health care professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program

    关注理由:这条肾脏病学资料适合作为深入阅读入口,尤其要关注研究方法与结论是否匹配。

  1. EMA · News and Safety Reviews

    精神医学:Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 26 - 29 October 2026

    原文摘录:Image credit: © tadamichi | stock.adobe.com Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 26 - 29 October 2026 30 October 2026 PRAC starts review of depression and anxiety medicine Deanxit and a safety signal related to hu … eu All other enquiries please submit your request via the online form Follow us on Bluesky Related medicine information Flupentixol/melitracen-containing medicinal products - referral Topics Pharmacovigilance

    关注理由:如果关注精神医学,这篇内容值得阅读其研究对象、方法设计和主要发现。

  2. FDA · MedWatch Safety Alerts

    血液病学:Platelet Factor 4 (PF4) Radioimmunoassay Recall: Instrumentation Laboratories Removes HemosIL AcuStar HIT-IgG(PF4-H)

    原文摘录:This recall involves removing certain devices from where they are used or sold. The FDA has identified this recall as the most serious type. This device may cause serious injury or death if you continue to use it. … Health care professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program

    关注理由:这篇血液病学资料可用于了解领域进展,研究设计、结果和局限性值得一起阅读。

  1. EMA · News and Safety Reviews

    儿科学:AMA and EMA issue joint guidance on Ebola vaccine development

    原文摘录:Image credit: © peterschreiber.media | stock.adobe.com AMA and EMA issue joint guidance on Ebola vaccine development 23 October 2026 Clinical trial requirements defined for rapid development of Bundibugyo virus vaccines News Human Clinical trials Research … eu All other enquiries Please submit your request via the online form

    关注理由:这条儿科学资料涉及临床试验,入组条件、对照设置和研究阶段可以帮助判断结果适用于哪些人群。

  1. FDA · MedWatch Safety Alerts

    呼吸病学:Update: Import Alert for Certain Olympus Medical Devices Manufactured in Japan - Letter to Health Care Providers

    原文摘录:October 20, 2026 The U.S. Food and Drug Administration (FDA) is alerting health care providers about an import alert for certain medical devices manufactured in Japan by Olympus Medical Systems Corporation (Olympus) and its subsidiaries. … Additional Resources Import Alert 89-04 [10/19/2026] FDA Issues Two Warning Letters to Leading Manufacturer of Endoscopes [01/10/2023] Warning Letters Olympus Medical Systems Corporation Warning Letter [10/07/2026] Olympus Medical Systems Corporation Warning Letter (Hinode) [03/15/2023] Olympus Medical Systems Corporation Warning Letter (Hachioji-shi) [12/12/2022] Aizu Olympus Warning Letter [11/02/2022] Infections Associated with Reprocessed Duodenoscopes [06/30/2022] Infections Associated with Reprocessed Urological Endoscopes - Letter to Health Care Providers [04/01/2021]

    关注理由:这条呼吸病学内容涉及相关临床或研究问题,建议查看原文中的方法与适用范围。

  2. FDA · MedWatch Safety Alerts

    儿科学:Early Alert: Cardinal Health Updates Use Instructions for Presource Packs Containing BD Alaris Pump Infusion Sets

    原文摘录:CDRH is issuing this Early Alert to notify the public of a potentially high-risk device issue. The FDA will keep the public informed and update this web page as significant new information becomes available. … Health care professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program

    关注理由:这条儿科学资料涉及具体临床问题,研究人群、方法和结局指标可以结合原文进一步查看。

  1. EMA · News and Safety Reviews

    内分泌与代谢:Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 October 2026

    原文摘录:Image credit: © Marcos Osorio/Stocksy | stock.adobe.com Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 October 2026 16 October 2026 Six new medicines recommended for approval; another five medicines recommended for … eu All other enquiries please submit your request via the online form Follow us on Bluesky Related medicine information Foundayo Rasonque Yuviwel Fovlussea Neuzafy Kizfizo Kyinsu Talvey Tukysa Tryngolza Yartemlea Mylotarg Truqap Ibrance

    关注理由:这条内分泌与代谢资料涉及具体临床问题,研究人群、方法和结局指标可以结合原文进一步查看。

  1. EMA · News and Safety Reviews

    肿瘤学:EMA recommends authorisation of Rasonque for metastatic pancreatic cancer

    原文摘录:Image credit: © Chinnapong | stock.adobe.com EMA recommends authorisation of Rasonque for metastatic pancreatic cancer 15 October 2026 Phased review fast tracks assessment of medicine addressing unmet medical need News Human Innovation Medicines EMA’s hum … eu All other enquiries Please submit your request via the online form Follow us on Bluesky Related medicine information Rasonque

    关注理由:这条肿瘤学内容涉及相关临床或研究问题,建议查看原文中的方法与适用范围。

已经到底了